ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 186 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $2,395,000 | +51.8% | 348,600 | +19.3% | 0.52% | +194.9% |
| Q3 2014 | $1,578,000 | +39.2% | 292,300 | +64.2% | 0.18% | +31.9% |
| Q2 2014 | $1,134,000 | +10.2% | 178,000 | +39.4% | 0.14% | -24.2% |
| Q1 2014 | $1,029,000 | – | 127,700 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,000,000 | $96,720,000 | 33.30% |
| Opaleye Management Inc. | 1,670,000 | $13,460,000 | 9.94% |
| Slate Path Capital LP | 6,620,000 | $53,357,000 | 4.04% |
| Granite Point Capital Management, L.P. | 648,000 | $5,223,000 | 3.74% |
| Palo Alto Investors LP | 6,917,248 | $55,754,000 | 2.30% |
| Camber Capital Management LP | 3,000,000 | $24,180,000 | 1.90% |
| Geduld E E | 277,600 | $2,237,000 | 1.21% |
| Elk Creek Partners, LLC | 290,886 | $2,345,000 | 1.01% |
| SELZ CAPITAL LLC | 400,000 | $3,224,000 | 0.81% |
| GENERAL AMERICAN INVESTORS CO INC | 1,200,000 | $9,672,000 | 0.81% |